pharmaphorum

OCTOBER 18, 2022

Listening to patients, patient advocacy groups, and others allows for better design of trial protocols, shaping tailored recruiting strategies, and helping to define what DCT solutions, including technologies, may most effectively and efficiently keep patients interested in, helping successful drug development to continue.

Drug Development 98

Drug Development Communication Vaccines 98

pharmaphorum

JANUARY 13, 2022

Others include a partnership between Biogen and Sangamo and Eli Lilly’s $1 billion takeover of Prevail in 2020, as well as a now-defunct alliance between AbbVie and Voyager in 2019, based on gene therapy approaches to target the rogue protein. Despite the interest, there have already been some failures in the alpha-synuclein category.

Immunity 98

Immunity Immunization Vaccines Drug Development 98

pharmaphorum

SEPTEMBER 27, 2021

The pharmaceutical industry is one of the most important industries in the world, providing lifesaving drugs and treatment to people who need it the most. trillion by end of 2020. Vaccine hesitancy was the most recent and highest profile example of distrust among minority groups towards the pharmaceutical industry.

Vaccines 122

Vaccines Communication Drug Development 122

pharmaphorum

APRIL 11, 2022

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. Delivering value for patients doesn’t start and end in our R&D labs; actions can be implemented across all stages of the drug development lifecycle to encourage and embrace a pro-innovation environment.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

European Pharmaceutical Review

DECEMBER 26, 2023

Production cost is currently a fundamental concern for many gene therapy developers, particularly given that some treatments cost millions of dollars per single dose (eg, $3.5 Single-use bioprocessing technologies enabling more rapid vaccines production [Internet]. million for Hemgenix [AAV5-hFIX-Padua]). Trends in Biotechnology.

Drug Pricing 98

Drug Pricing Packaging Vaccines Drug Development 98

pharmaphorum

SEPTEMBER 18, 2020

However, it withdrew its neuropharmacological drug, Zelmid, which was an SSRI, due to concerns over side effects only a year after it was introduced in 1982. In 1990, the US Food and Drug Administration (FDA) requested Astra to change Losec’s brand name to Prilosec, to avoid confusion with Sanofi-Aventis’ diuretic, Lasix (furosemide).

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

pharmaphorum

OCTOBER 28, 2020

Data defines modern therapeutics, but this is almost uniquely confined to the clinical trial stages of drug development. In the UK, for example, more than half the public expressed an unwillingness to take a vaccine unless it had been tested for at least a year. 72% do not feel listened to by pharmaceutical companies.

Vaccines 119

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 119

pharmaphorum

SEPTEMBER 9, 2021

But when the pandemic struck in early 2020, we were found wanting. Surgical activity in England and Wales alone reduced by a third during 2020, a shortfall estimated to increase to 2.4 The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

SEPTEMBER 26, 2022

GlobalData’s Contract Service Provider database shows that Novartis has 25 manufacturing sites in the US, Europe and China, including five API biologics (cell, gene, vaccine and virus) facilities in the US, France and Switzerland. These highlight the parent company’s focus on innovative and high-value drug development.

Biosimilars 64

Biosimilars Drug Development Vaccines Dosage 64

pharmaphorum

SEPTEMBER 30, 2020

Considering this, we are delighted to announce the release of the agenda for the 2 nd Digital Exosome Based Therapeutic Development Summit (November 11-12, 2020). Innovations in exosome-based therapeutics, such as their applications in COVID-19 vaccines with Capricor Therapeutics.

Hospitals 52

Hospitals Vaccines Drug Development 52

pharmaphorum

JANUARY 18, 2022

million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. Smart device developers. Training device developers. Drug developers. Device innovations, connected delivery and regulatory guidance for advanced parenteral systems. Medical Device Engineers.

Packaging 52

Packaging Documentation Vaccines Drug Development 52

Putting Patients First Blog

APRIL 30, 2024

Assessment of length and readability of informed consent documents for COVID-19 vaccine trials. A blueprint for developing patient-centered core impact sets (PC-CIS). Re: Patient-Focused Drug Development: Guidance 1 – Collecting Comprehensive and Representative Input; Public Workshop (Docket No. Sincerely, Randall L.

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

European Pharmaceutical Review

JANUARY 16, 2023

The safety and efficacy of mRNA vaccines should be a game changer and is the likely solution to antibiotic-resistant microorganisms and emerging viral pathogens.” The previous record for vaccine development and approval was four years for the measles vaccine.

Vaccines 128

Vaccines Research Laboratories Documentation Compounding 128

Pharmaceutical Technology

AUGUST 17, 2022

It will also have the potential to scale to Phase III clinical development and commercial manufacturing. Furthermore, the CDMO provides various customisable development and manufacturing scales according to the requirements of drug developers in various regions globally. .

Vaccines 52

Vaccines Drug Development 52

Pharmaceutical Technology

JULY 23, 2008

Despite the enormous growth being enjoyed by the global oncology market, potential cancer cures are left on laboratory shelves on a regular basis, according to Dr Victoria John, head of clinical partnerships at Cancer Research UK’s Drug Development Office. “You can get vaccines now to prevent cervical cancer.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Compounding Biosimilars 40

pharmaphorum

FEBRUARY 19, 2021

While the pandemic has been the focus of R&D attention for much of 2020, that is slowly beginning to shift towards other projects in the big pharma pipeline. Biogen also gained a lot of attention thanks to one of the most-watched drugs in the pharma pipeline.

Vaccines 45

Vaccines Drug Development 45

European Pharmaceutical Review

DECEMBER 22, 2022

The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category” The term ‘mRNA’ has become commonplace globally. The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category.

Immunity 116

Immunity Immunization Vaccines Hospitals 116

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. This was higher than the number of approvals in 2019 and 2020. Several drug development trends are driving injectables demand.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

JANUARY 31, 2023

Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Founded Year: 2020 No. With an aim to develop a VLP-based vaccine candidate, Frazier and Takeda Pharmaceuticals underwent a collaboration to form Hillevax.

Vaccines 40

Vaccines Immunity Immunization Diabetes 40

pharmaphorum

JUNE 24, 2022

The initiative will focus on vaccines and medicines for diseases like malaria, tuberculosis, HIV and neglected tropical diseases (NTDs), which according to the drugmaker account for 60% of the disease burden in poorer regions of the world, as well as antimicrobial resistance. GSK will invest around £1 billion ($1.2

Vaccines 59

Vaccines Immunity Immunization Drug Development 59

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. Excluding vaccines, there are five mRNA therapeutic products in clinical trial development as of November 2022.

Vaccines 52

Vaccines Drug Development Documentation Communication 52

Pharmaceutical Technology

MARCH 1, 2023

The Covid-19 pandemic led to massive developments and scientific advances within the field of messenger ribonucleic acid (mRNA) vaccines. Pfizer /BioNTech and Moderna’s mRNA-based vaccines were the first to receive emergency use authorisation (EUA) out of all other Covid-19 vaccines under development in late 2020.

Vaccines 59

Vaccines Drug Development Diabetes 59

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . BioNTech seeks “new kind of pharma company”.

Drug Development 93

Drug Development Vaccines Documentation Communication 93

pharmaphorum

NOVEMBER 8, 2022

Due to the pandemic, decentralised trial solutions made the shift from an emerging trend to a crucial element of drug development. The pharmaceutical industry’s role in developing effective vaccines against COVID-19 was a major benefit to the industry.

Vaccines 121

Vaccines Drug Development 121

pharmaphorum

JANUARY 10, 2022

There are still licensing deals to be done in the COVID-19 category it seems, after Novartis paid around $163 million to license rights to an antiviral drug developed by Molecular Partners. Amgen and AbbVie are also collaborating with Molecular Partners on DARPin candidates for cancer and ophthalmic diseases, respectively.

Vaccines 52

Vaccines Drug Development 52

Pharmaceutical Technology

FEBRUARY 20, 2023

We are delighted to deepen our partnership with Teddy Lab that will enable us to build on existing knowledge and increase services within China to support customers with their global drug development programmes. Particularly, Teddy Lab Wuxi set up in 2020 with the great help of Wuxi Government. SZ) and Tigermed (300347.SZ

Research Laboratories 52

Research Laboratories Drug Development Vaccines Communication 52

pharmaphorum

DECEMBER 10, 2020

In the last few years it has been progressively adding to its capabilities, for example buying oncolytic virus specialist ViraTherapeutics in 2018 and cancer vaccine player AMAL Therapeutic s last year.

Vaccines 59

Vaccines Immunity Immunization Drug Development 59

Pharmaceutical Technology

FEBRUARY 20, 2023

On the other hand, a lack of diversity in clinical trial populations, particularly when the disease population is significantly underrepresented, greatly diminishes the quality of data obtained for drug safety and efficacy profiles. This may sound obvious, but it is still a major hurdle in drug development.

Vaccines 52

Vaccines Communication Immunity Immunization 52

Putting Patients First Blog

MARCH 29, 2023

They primarily focus on improving the public health infrastructure, improving the development of treatment and vaccines, and coordinating federal response. These flexibilities and partnerships greatly increased the speed of research and development for COVID-19 testing, treatment, and vaccines. Sincerely, Randall L.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Vaccines Documentation Hospitals 40

Pharmaceutical Technology

AUGUST 1, 2022

Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies Chemotherapy 93

STAT

MARCH 6, 2023

Still, when doctors told her last year that the cancer was growing despite two operations, radiation therapy, and a fifth regimen of chemotherapy, the retired business-meeting facilitator decided to do something unorthodox: spend $83,000 out of pocket on an unproven experimental cancer vaccine.

Vaccines 246

Vaccines Bioethics Immunity Immunization 246

Pharmaceutical Technology

MAY 5, 2023

The WHO Director-General concurred with the advice of the committee, officially ending what had been deemed a public health emergency of international concern (PHEIC) since March 2020. There are more than 1,000 ongoing drug and vaccine trials targeting Covid-19, according to GlobalData’s Clinical Trials Database.

Vaccines 52

Vaccines Drug Development 52

pharmaphorum

SEPTEMBER 1, 2020

Fordian methods enabled more rational methods of mass production, and increasing understanding of biology and chemistry enabled drug candidates to be chosen systematically rather than discovered serendipitously.

Diabetes 145

Diabetes Immunity Immunization Vaccines 145

European Pharmaceutical Review

FEBRUARY 3, 2025

What lessons can you offer to other manufacturers/drug developers? About the authors Shidong Shi, PhD Head of Upstream Process Development, Altruist Biologics Dr Shi joined Altruist Biologics in 2022 in his current role. This technology achieves higher process throughput, low labour cost, increased flexibility and reduced risk.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52